Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Novo Nordisk threatens legal action over Hims Wegovy copy (updated) Kimberly Redmond 6, 2026// The basics: Novo Nordisk warns Hims & Hers over $49 compounded, copycat version of Wegovy Drugmaker says product infringes on its branded GLP-1 treatment Hims offering lower-cost compounded weight-loss alternatives amid soaring demand Dispute highlights growing tension between brand-name pharma, telehealth platforms Novo Nordisk vowed to take legal action against Hims & Hers after the telehealth platform launched a cheaper, copycat version of the pharmaceutical giants Wegovy GLP-1 weight loss pill
Hypoglycaemia: Retatrutide's insulin-stimulating effects are glucose-dependent, which reduces but does not eliminate the risk of low blood glucose
Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity
Western blot density quantification was performed using ImageJ software 36 and are displayed in Supplementary Fig
